For example, KRAS, BRAF and PIK3CA may have prognostic values in CRC [8], mutation detection of combination of KRAS, BRAF and PIK3CA could contribute to predict the response of CRC patients to EGFR pathway inhibitors [9]. The gene discussed is PIK3CA; the disease is colorectal carcinoma.